Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis

被引:48
作者
Hall, CR
Cole, WG
Haynes, R
Hecht, JT
机构
[1] Univ Texas, Houston Med Sch, Dept Pediat, Houston, TX 77030 USA
[2] Hosp Sick Children, Dept Surg, Toronto, ON, Canada
[3] Shriners Hosp Houston, Houston, TX USA
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 112卷 / 01期
关键词
hereditary multiple exostosis (HME); EXT1; EXT2; EXTL; loss of heterozygosity (LOH); chondrocytes; perichondrium;
D O I
10.1002/ajmg.10635
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
EXT1 and EXT2 are genes that have been shown to cause hereditary multiple exostosis (HME), a syndrome marked by the formation of bony growths juxtaposed to the growth plate. These genes are members of a growing family of proteins with glycosyltransferase activity required for the synthesis of heparan sulfate chains. This protein activity is predicted to play a role in the expression of proteoglycans on the cell surface and in the extracellular matrix. We and others have previously suggested that a two-hit mutational model applies to the development of an exostosis where a germline mutation coupled with a somatic mutation results in the loss of EXT1 or EXT2 function and subsequent tumor formation. We report the direct sequencing and loss of heterozygosity (LOH) analysis of 12 exostoses from 10 HME families, 4 solitary exostoses, and their corresponding constitutional DNA. Of the 16 exostoses screened, we find only one solitary case in which two somatic mutations, a deletion and an LOH, are present. This provides limited support for the two-hit hypothesis involving the EXT1 and EXT2 genes for the development of an exostosis. Alternative models are developed based on the functional significance of EXT proteins in heparan sulfate biosynthesis. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 48 条
[1]   CLONING OF THE PUTATIVE TUMOR-SUPPRESSOR GENE FOR HEREDITARY MULTIPLE EXOSTOSES (EXT1) [J].
AHN, J ;
JOSEFLUDECKE, H ;
LINDOW, S ;
HORTON, WA ;
LEE, B ;
WAGNER, MJ ;
HORSTHEMKE, B ;
WELLS, DE .
NATURE GENETICS, 1995, 11 (02) :137-143
[2]   Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations [J].
Bernard, MA ;
Hogue, DA ;
Cole, WG ;
Sanford, T ;
Snuggs, MB ;
Montufar-Solis, D ;
Duke, PJ ;
Carson, DD ;
Scott, A ;
Van Winkle, WB ;
Hecht, JT .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (03) :442-450
[3]  
Bernard MA, 2001, CELL MOTIL CYTOSKEL, V48, P149, DOI 10.1002/1097-0169(200102)48:2<149::AID-CM1005>3.0.CO
[4]  
2-3
[5]   EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas [J].
Bovée, JVMG ;
Cleton-Jansen, AM ;
Wuyts, W ;
Caethoven, G ;
Taminiau, AHM ;
Bakker, E ;
Van Hul, W ;
Cornelisse, CJ ;
Hogendoorn, PCW .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (03) :689-698
[6]  
Deere M, 1998, AM J MED GENET, V80, P510, DOI 10.1002/(SICI)1096-8628(19981228)80:5<510::AID-AJMG14>3.0.CO
[7]  
2-F
[8]   Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses [J].
Dobson-Stone, C ;
Cox, RD ;
Lonie, L ;
Southam, L ;
Fraser, M ;
Wise, C ;
Bernier, F ;
Hodgson, S ;
Porter, DE ;
Simpson, AHRW ;
Monaco, AP .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (01) :24-32
[9]   Genotype-phenotype correlation in hereditary multiple exostoses [J].
Francannet, C ;
Cohen-Tanugi, A ;
Le Merrer, M ;
Munnich, A ;
Bonaventure, J ;
Legeai-Mallet, L .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (07) :430-434
[10]  
HECHT JT, 1995, AM J HUM GENET, V56, P1125